Doxorubicin affects testicular lipids with long-chain (C18-C22) and very long-chain (C24-C32) polyunsaturated fatty

Samanta R Zanetti1, Eduardo N Maldonado, Marta I Aveldaño

  • 1Instituto de Investigaciones Bioquímicas de Bahía Blanca, Consejo Nacional de investigaciones Científicas y Técnicas y Universidad Nacional del Sur, La Carrindanga km. 7, 8000 Bahía Blanca, Argentina.

Cancer Research
|July 20, 2007
PubMed

Insights

Doxorubicin chemotherapy significantly alters testicular lipids and fatty acids in adult rats, impacting germ cell development and lipid composition. This study reveals chemotherapy-induced changes in phospholipids, sphingomyelin, and accumulating cholesterol esters in testes.

Area of Science:

  • Reproductive Biology
  • Toxicology
  • Biochemistry

Background:

  • Doxorubicin is a potent chemotherapy agent known to induce apoptosis in germ cells, disrupting spermatogenesis.
  • The precise impact of doxorubicin on testicular lipid metabolism and fatty acid profiles remains incompletely understood.

Purpose of the Study:

  • To investigate the effects of single and multiple doxorubicin doses on adult rat testicular lipids and their fatty acid composition.
  • To identify specific lipid classes and fatty acids affected by doxorubicin-induced testicular toxicity.

Main Methods:

  • Adult rats were administered single or multiple doses of doxorubicin.
  • Testicular size, weight, and lipid profiles, including phospholipids, sphingomyelin, triglycerides, and cholesterol esters, were analyzed over 9 weeks.
  • Fatty acid composition of these lipids was determined using gas chromatography.

Main Results:

  • Doxorubicin treatment led to significant testicular atrophy and germ cell loss.
  • Phospholipids and sphingomyelin decreased, with selective loss of specific polyunsaturated fatty acids (PUFAs) and very long-chain PUFAs (VLC-PUFAs) associated with germ cells.
  • Triglycerides and cholesterol esters accumulated, particularly in Sertoli and possibly steroidogenic cells, with altered fatty acid profiles, including increased 20:4n-6.

Conclusions:

  • Doxorubicin significantly alters testicular lipid metabolism, with germ cell loss correlating to specific PUFA and VLC-PUFA depletion in phospholipids and sphingomyelin.
  • Accumulation of cholesterol esters in surviving somatic cells suggests a shift in testicular lipid handling following chemotherapy.
  • These findings highlight the complex biochemical changes in the testis induced by doxorubicin, impacting both germ and somatic cell lipid profiles.

Related Concept Videos